|
|||||
|
|
Pharmacokinetic and pharmacodynamic properties of plasma‐derived vs. recombinant factor IX in patients with hemophilia B: a prospective crossover study |
|
| Authors: | J. Alamelu D. Bevan B. Sorensen S. Rangarajan |
| Abstract: | |
| Keywords: | factor IX half‐life hemophilia B pharmacodynamics pharmacokinetics |